-25% en todo – hasta el 31 de octubreEnvío gratis en pedidos desde $99
Biotech Peptides

Uso del producto: Este producto está destinado exclusivamente a la investigación.

Toda la información de los productos de este sitio web tiene fines exclusivamente educativos. Cualquier forma de introducción en el cuerpo de personas o animales está estrictamente prohibida por la ley. Este producto solo debe ser manipulado por profesionales autorizados y cualificados. No es un medicamento, alimento ni cosmético y no debe etiquetarse, utilizarse ni presentarse como tal.

IGF-1 LR3 1mg

IGF-1 LR3 (Long Arg3-IGF-1) is a synthetic 83-amino-acid analogue of insulin-like growth factor 1, engineered with an N-terminal 13-amino-acid extension and an Arg3 substitution that together confer markedly reduced affinity for IGF-binding proteins (IGFBPs) and extended plasma half-life.

La misma fórmula de confianza. Nuevo diseño.

Durante el cambio de envase, puedes recibir productos con la etiqueta anterior o con la nueva. La formulación, la pureza y la calidad siguen siendo exactamente las mismas, según nuestros estándares.

Métodos de pago aceptados
  • Tarjeta de crédito
  • Transferencia bancaria (SEPA inmediata)
  • Transferencia bancaria (ACH)
  • Wise
  • Revolut
  • Zelle
  • Remitly
  • Western Union
  • Chime
  • Otros

-25% en todo – hasta el 31 de octubre
25% sobre los precios habituales, en sustitución de otras ofertas. Acumulable solo con el descuento crypto.

Envío

Envío en el día para pedidos en EE. UU. realizados antes de las 12:00 EST.

Ver la política de envíos →
Devoluciones

Devoluciones sin complicaciones en 30 días para productos sin abrir.

Ver la política de devoluciones →
Analizado en laboratorio

Cada lote se analiza para comprobar su pureza, potencia y calidad.

Ver resultados de laboratorio →
Atención al cliente

¿Tienes alguna pregunta? Escríbenos por Telegram.

Abrir el chat →

IGF-1 LR3 (Long Arg3-IGF-1) is a synthetic 83-amino-acid analogue of insulin-like growth factor 1, engineered with an N-terminal 13-amino-acid extension and an Arg3 substitution that together confer markedly reduced affinity for IGF-binding proteins (IGFBPs) and extended plasma half-life. These modifications preserve IGF-1 receptor (IGF-1R) agonist activity while reducing IGFBP sequestration, enabling sustained receptor engagement in preclinical research models.

  • High Purity – 99% Purity Guaranteed
  • Independently Lab Tested
  • Research Grade Quality
  • For Laboratory Research Use Only
All Biotech Peptides products are independently third-party tested at a USA-based HPLC-licensed laboratory prior to distribution. Certificates of Analysis (COA) are published on the Independent Test Results page and available at product level. If any independently conducted HPLC test returns a negative result, Biotech Peptides will refund: (1) the cost of the HPLC test, and (2) the full order amount including shipping.
Chemical Formula C400H625N111O115S9
Synonyms Long R3-IGF-1, M9L22Y19H9, 143045-27-6, Long-(arg3)insulin-like growth factor-i
Molar Mass 9,117.60 g/mol
CAS Number 143045-27-6
PubChem CID N/A
Total Compound Content 1 mg per vial
Shelf Life 36 months
IGF-1 LR3 is a recombinant 83-amino-acid analogue of native IGF-1 (70 AA) featuring two structural modifications: an N-terminal 13-residue extension (MFPAMPLLSLFVN) and substitution of glutamic acid at position 3 with arginine (Arg3). These changes reduce IGFBP-1 through IGFBP-6 binding affinity by approximately 1,000-fold relative to native IGF-1, effectively eliminating IGFBP sequestration and increasing the proportion of free, biologically active peptide in experimental systems. Full IGF-1R agonist activity is preserved, with downstream activation of PI3K/Akt, MAPK/ERK, and mTOR signalling cascades. Plasma half-life extends to approximately 56–72 hours versus approximately 10–20 minutes for native IGF-1. Researchers use IGF-1 LR3 to investigate IGF-1R signalling in sustained-activation contexts, anabolic pathway regulation, and the consequences of IGFBP-uncoupled IGF-1R engagement on cell proliferation, differentiation, and metabolic substrate utilisation. Supplied as lyophilised preparation (1 mg/vial). Independently third-party HPLC-tested; COA available per batch.

Results refer to the tested sample. Check the batch and date in the report.

IGF-1 LR3 (2607-CY-IG)
September 13, 2026
IGF-1 LR3 (AY0811-LR)
September 4, 2026
Why does IGF-1 LR3 have a longer half-life than native IGF-1?

Native IGF-1 is rapidly sequestered in circulation by IGF-binding proteins (IGFBPs 1–6), which extend its half-life but also restrict bioavailability. The Arg3 substitution and N-terminal 13-residue extension in IGF-1 LR3 reduce IGFBP affinity by approximately 1,000-fold, preventing this sequestration.

Without IGFBP binding, IGF-1 LR3 remains in free, receptor-accessible form for 56–72 hours — substantially longer than native IGF-1's 10–20-minute half-life when not IGFBP-bound.

Which intracellular signalling pathways does IGF-1 LR3 activate via IGF-1R?

IGF-1R is a receptor tyrosine kinase. Ligand binding drives receptor autophosphorylation, IRS-1/IRS-2 adapter recruitment, and activation of two primary downstream cascades: PI3K/Akt/mTOR (governing protein synthesis, glucose uptake, and cell survival) and MAPK/ERK (regulating cell proliferation and differentiation). Both pathways are fully engaged by IGF-1 LR3 at the IGF-1R, identical to native IGF-1.

What types of experimental programs are most suited to the IGF-1 LR3 10-vial KIT format?

The IGF-1 LR3 KIT format is particularly useful for longitudinal investigations, multi-arm experimental designs, concentration-response studies, receptor-signaling experiments, and pathway-characterization programs that require repeated compound preparation over extended periods.

The availability of multiple matched-batch vials supports consistent experimental conditions across separate study phases, treatment groups, and sampling timepoints. This makes the KIT format well-suited to research involving IGF-1 receptor signaling, PI3K/Akt/mTOR pathway analysis, MAPK/ERK pathway investigation, and comparative insulin-like growth factor pharmacology.

Customer Reviews (6)

★★★★★ ★★★★★
5 / 5
5★
6
4★
0
3★
0
2★
0
1★
0
★★★★★ ★★★★★
Verified Buyer
Pavel O.

Amazing product. Will order again.

★★★★★ ★★★★★
Verified Buyer
Gray

Affordable price. Great service.

★★★★★ ★★★★★
Verified Buyer
Robinson

I adore everything about this site, especially IGF

★★★★★ ★★★★★
Verified Buyer
Max

Highly satisfied with the product quality. Will order again soon.

★★★★★ ★★★★★
Verified Buyer
Catalyst

Top-notch quality from the prompt communication, the chemical quality is top notch. Our research results have been outstanding. Will purchase again soon.